Your dog was diagnosed with Soft Tissue Sarcoma, Grade I–II (Wide Excision Feasible). STS represents a heterogeneous group of mesenchymal tumours with similar biological behaviour. Grade I–II tumours are locally invasive but metastatic potential is low (Grade I ~7% recurrence, Grade II ~34% recurrence after marginal excision). Compare 2 treatment options for dogs including Wide Surgical Excision, Surgical Excision + Post-Operative Radiation Therapy — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Soft Tissue Sarcoma, Grade I–II (Wide Excision Feasible)
Canine Oncology Treatment Guide
Soft Tissue Sarcoma, Grade I–II (Wide Excision Feasible)
Mesenchymal
About This Cancer
Soft tissue sarcomas are a diverse group of cancers arising from connective tissues such as fat, muscle, fibrous tissue, nerves, and blood vessel walls. Despite their varied cell origins, these tumours share similar biological behaviour: they grow as locally invasive masses that infiltrate surrounding tissues along fascial planes, making them appear smaller on the surface than they truly are beneath the skin. Grade I–II tumours grow relatively slowly and have a low chance of spreading to distant organs, but they can recur locally if surgical margins are not wide enough. The key to successful treatment is achieving complete surgical removal with generous margins at the first operation, as recurrences tend to be more difficult to excise completely. Large breed dogs are generally overrepresented, and these tumours most commonly appear on the trunk or extremities.
STS Grading System (Kuntz)
Based on mitotic index, degree of differentiation, and percentage of necrosis.
Prognostic Factors(2)
Minimum Workup(5 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.